Researchers have developed a new method for creating custom tailored, two stage therapies for glioblastoma brain cancer.
Researchers have developed a new experimental approach to treating medulloblastoma brain cancer.
Researchers identify two adult cancer medications which have the potential to improve treatment for medulloblastoma brain cancer in children.
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain.
Brain cancer cells resist therapy by temporarily losing gene mutations targeted by drugs, but re-amplify the mutation once the treatments have stopped, a new study reports.
Researchers discover an enzyme, IDH, which facilitates the breakdown of specific amino acids makes glioblastoma brain cancer particularly aggressive.
Researchers discover glioblastoma brain tumor cells disrupt the blood brain barrier. The findings offer potential new avenues to treat brain cancer.
A pioneering ultrasound treatment could help treat hypothalamic hamartomas, a rare, benign mass in the brain that can cause epilepsy symptoms and unintentional giggling seizures.
A new study reveals how the ACSS2 enzyme allows brain tumors to grow in a nutrient starved environment.
Researchers report an experimental treatment has shown to be able to stop treatment resistant glioblastoma in human cells and mouse models.
Researchers identify the most common genetic alteration in ependymoma brain tumors.
According to researchers, new evidence suggest survivors of childhood cancers have higher risk of suffering a stroke at a young age.
